Schott Extends License to Accelr8's Microarray Slide-Coating Technology | GenomeWeb
NEW YORK (GenomeWeb News) — Accelr8 today said it has extended a
licensing agreement with Schott  Nexterion that allows Schott to use its surface-coating chemistry to make and market microarray slides.
 
Under the new two-year agreement, Schott will have access to a version of Accelr8’s OptiChem product to produce its Slide HS microarraying slides.
 
The OptiChem technology uses a protein to create an even and stable slide surface, according to Accelr8.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.